[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100583571":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":11,"centralContacts":23,"locations":11,"responsibleParty":29,"collaborators":11,"id":32,"slug":33,"hasResults":34,"nctId":35,"briefTitle":36,"officialTitle":36,"acronym":37,"eligibilityCriteria":38,"healthyVolunteers":34,"sex":39,"minAge":40,"maxAge":41,"enrollmentInfo":42,"targetDuration":11,"studyType":45,"phases":46,"briefSummary":48,"conditions":49,"keywords":11,"overallStatus":51,"whyStopped":11,"lastUpdateSubmitDate":52,"lastUpdatePostDateStruct":53,"startDateStruct":56,"completionDateStruct":58,"leadSponsor":60,"locationsCount":11},{"fullName":5,"class":6},"Poissy-Saint Germain Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"ethanol sclerotherapy group","EXPERIMENTAL",null,[13],"Procedure: ethanol sclerotherapy",{"label":15,"type":16,"description":11,"interventionNames":11},"group without intervention","NO_INTERVENTION",[18],{"type":19,"name":20,"description":21,"armGroupLabels":22,"otherNames":11},"PROCEDURE","ethanol sclerotherapy","The originality of this project consists in evaluating the effectiveness of ethanol sclerotherapy of endometrioma(s) in infertile patients before IVF\u002FICSI, excluding patients who have previously had an ovarian cystectomy. To date, no prospective randomized comparative study between ethanol sclerotherapy of endometriomas and therapeutic abstention has been carried out.",[9],[24],{"name":25,"role":26,"phone":27,"phoneExt":11,"email":28},"Nelly SWIERKOWSKI-BLANCHARD, MD","CONTACT","+33139275259","nelly.swierkowskiblanchard@ght-yvelinesnord.fr",{"type":30,"investigatorFullName":25,"investigatorTitle":31,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"PRINCIPAL_INVESTIGATOR","MD","100583571","benefit-of-ethanol-sclerotherapy-of-endometriomas-before-ovarian-stimulation-on-pregnancy-rates-in-ivficsi-100583571",false,"NCT06878053","Benefit of Ethanol Sclerotherapy of Endometriomas Before Ovarian Stimulation on Pregnancy Rates in IVF\u002FICSI","SCLERENDO","Inclusion Criteria:\n\n* Infertile women aged 18 to 43,\n* Presenting one or 2 endometriotic cysts of 30 mm to 80 mm long axis, confirmed by ultrasound and\u002For pelvic MRI and without signs of atypia,\n* With indication of IVF\u002FICSI, first IVF\u002FICSI after the discovery of endometriosis cyst(s),\n* Having given their consent.\n\nExclusion Criteria:\n\n* A history of ovarian cystectomy,\n* A non-homogeneous cyst that cannot be punctured (risk of incomplete aspiration),\n* Complex adnexal image that cannot exclude an associated hematosalpinx (communicating hematosalpinx, tissue component),\n* A recent tubo-ovarian infection,\n* An active, untreated vaginal infection,\n* Anticoagulant treatment at a therapeutic dose,\n* All adult patients protected by law (under guardianship or curatorship),\n* Problems understanding the French language,\n* Participation in intervention research,\n* All patients not affiliated to the social security system.","FEMALE","18 Years","43 Years",{"count":43,"type":44},174,"ESTIMATED","INTERVENTIONAL",[47],"NA","Evaluation of progressive pregnancy rates (with an embryo with cardiac activity at 12 weeks), on a first attempt at IVF\u002FICSI (fresh and frozen embryo transfers) following the discovery of one or two endometrioma(s) of 30 to 80 mm, without a history of cystectomy, and comparison between the two groups: ethanol sclerotherapy and therapeutic abstention",[50],"Infertile Women Undergoing IVF or ICSI","NOT_YET_RECRUITING","2025-03-10",{"date":54,"type":55},"2025-03-14","ACTUAL",{"date":57,"type":44},"2025-06-01",{"date":59,"type":44},"2029-06-01",{"name":5,"class":6}]